Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Leading cardiologists sound the alarm, say polypills could save millions of lives if made widely available

“This systemic failure is a global tragedy, as many premature deaths from CVD could be avoided,” one cardiologist said. 

FDA confirms nationwide shortage of Adderall

Manufacturers, it seems, are unable to keep up with high demand. 

Impella Heart Pump Abiomed RECOVER IV RCT cardiogenic shock

Impella heart pumps linked to improved high-risk PCI outcomes

Researchers examined data from patients who underwent high-risk PCI with either an Impella heart pump or an intra-aortic balloon pump.

New evidence that heart damage risk is much higher after COVID-19 infection than after vaccination

The new meta-analysis, published in Frontiers in Cardiovascular Medicine, included data from 58 million patients. “We hope our findings will help mitigate vaccine hesitancy and increase vaccine uptake," one researcher said. 

An updated look at how cognitive impairment affects TAVR outcomes

The connection between cognitive impairment and postoperative delirium among TAVR patients stood out as a definite concern to the study's authors.

Thumbnail

PET/CT findings predict post-treatment, radiation-induced hypothyroidism

Radiation-induced hypothyroidism is common yet underdiagnosed, potentially owing to a lack of follow-up consensus in patients treated with radiation therapy for head and neck cancers.

cardiologist Peter J. Fitzgerald, MD, PhD, HeartBeam

Cardiac technology startup names cardiologist Peter Fitzgerald its chief medical officer

Fitzgerald, a leading figure in interventional cardiology, praised the company's potential to improve patient outcomes and quality of life. 

Metformin, the popular type 2 diabetes medication, may be an effective AFib treatment

A team of specialists from Cleveland Clinic reviewed nearly 3,000 medications, writing that a common type 2 diabetes medication offered the most potential as an effective treatment for AFib.